The authors reply.
Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China, and Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA; Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA.
Sheng
S
Chen
Jiping
J
Tang
Jianmin
J
Zhang
John H
JH
Zhang
D000818:Animals; D004789:Enzyme Activation / Q000187:drug effects*; D008297:Male; D058920:Purinergic P2X Receptor Antagonists / Q000627:therapeutic use*; D012394:Rosaniline Dyes / Q000627:therapeutic use*; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy* / Q000201:enzymology*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
D058920:Purinergic P2X Receptor Antagonists; D012394:Rosaniline Dyes; D048051:p38 Mitogen-Activated Protein Kinases